https://www.prnewswire.com/news-releases/rational-vaccines-announces-a-clinical-trial-to-determine-baseline-characteristics-of-patients-diagnosed-with-recurrent-symptomatic-herpes-simplex-type--2-hsv-2-virus-301605324.html
/PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the...
Create an account or login to join the discussion